A comparison of budesonide and mesalamine for active Crohn's disease.
Lowry
P W
PW
Sandborn
W J
WJ
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D019804:Mesalamine / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D011239:Prednisolone / Q000627:therapeutic use; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D019804:Mesalamine; D019819:Budesonide; D011239:Prednisolone; D001379:Azathioprine